Clinical Significance, Pathogenesis, and Management of Postprandial Hyperglycemia
Open Access
- 9 June 2003
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 163 (11) , 1306-1316
- https://doi.org/10.1001/archinte.163.11.1306
Abstract
Review from JAMA Internal Medicine — Clinical Significance, Pathogenesis, and Management of Postprandial HyperglycemiaThis publication has 95 references indexed in Scilit:
- Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. U.K. Lispro Study Group.Diabetes Care, 1999
- The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitusJournal of Clinical Investigation, 1999
- Is glucose a continuous risk factor for cardiovascular mortality?Diabetes Care, 1999
- The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.Diabetes Care, 1999
- Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus.Journal of Clinical Investigation, 1998
- Pramlintide: A Human Amylin Analogue Reduced Postprandial Plasma Glucose, Insulin, and C-peptide Concentrations in Patients with Type 2 DiabetesDiabetic Medicine, 1997
- Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus.Journal of Clinical Investigation, 1996
- Lower-Extremity Amputations in Diabetic and Nondiabetic Patients: A population-based study in eastern FinlandDiabetes Care, 1993
- Importance of Timing of Preprandial Subcutaneous Insulin Administration in the Management of Diabetes MellitusDiabetes Care, 1983
- Diabetes and cardiovascular disease. The Framingham studyJAMA, 1979